🇺🇸 ACP in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 23

Most-reported reactions

1. Fatigue — 3 reports (13.04%)
2. Lethargy — 3 reports (13.04%)
3. Pyrexia — 3 reports (13.04%)
4. Acute Kidney Injury — 2 reports (8.7%)
5. Cough — 2 reports (8.7%)
6. Diarrhoea — 2 reports (8.7%)
7. Gastrointestinal Haemorrhage — 2 reports (8.7%)
8. Hyperhidrosis — 2 reports (8.7%)
9. Pain — 2 reports (8.7%)
10. Platelet Count Decreased — 2 reports (8.7%)

Source database →

Frequently asked questions

Is ACP approved in United States?

ACP does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for ACP in United States?

Istituto Ortopedico Rizzoli is the originator. The local marketing authorisation holder may differ — check the official source linked above.